Results: Around 10 percent of patients had sharp FBA in the airway. We noticed that they are overall older. They mostly have the same social background. Most of them gave clear history of sharp FBA. Imaging was useful in the majority of patients. Most sharp FBA happened with the same object.
Objective: Determine the safety of a primarily outpatient management protocol for children with sickle cell disease undergoing adenotonsillectomy.
Method: A retrospective chart review was conducted of children with sickle cell disease undergoing adenotonsillectomy over a four year period beginning January 2007 at an academic tertiary care facility. Preoperatively patients underwent transfusion for hemoglobin less than 10g/dL. Postoperatively, they were monitored overnight and discharged the following day when possible.
Results: Fifteen pediatric patients with homozygous sickle cell disease and one patient with sickle beta thalassemia disease were identified, all of whom underwent adenotonsillectomy. The majority of patients (11) were discharged on the first postoperative day with the average length of postoperative admission for all patients being 1.5 days (range, 1-5). Two patients (13 percent) experienced postoperative pain crises. There were no cases of postoperative bleeding, CVA, or acute chest syndrome.
Conclusion: Adenotonsillectomy in patients with sickle cell disease can be performed safely and effectively with careful outpatient preoperative management and brief postoperative hospitalization.
Pediatric Otolaryngology Steroids in Pediatric Bell Palsy: A Systematic Review
Koby Pitaro, MD (presenter); Sofia Waissbluth, MD; Sam J. Daniel, MD, FRCSC Objective: Conduct an updated systematic review on the outcome of Bell Palsy (BP) in children following steroid treatment.
Method: Medline, Embase, Cochrane Library, and BIOSIS Previews databases were searched obtaining articles from years 2000 to 2010 without any language restriction. Articles describing children aged 0 to 18 years with BP treated solely with corticosteroids were included. The outcome measure was facial movements based on clinical scales.
Results: A total of 2293 papers were initially identified. Following review by 2 authors, 68 papers were analyzed in a hard-copy format. Finally, 6 studies were eligible to be included in the systematic review. Four of the studies exclusively included children with BP where in 2; various etiologies of facial palsy were described. The nontreated groups were smaller than the treated groups. Type of steroid and duration of treatment were inconsistently specified. Outcome measures used include the House-Brackmann scale, Yanagihara grading system, and clinical evaluation. Studies analyzed were retrospective cohorts or case-series and were categorized as level 4 of evidence.
Conclusion: There were no controlled trials, and level 4 publications predominate. Therefore, the role of steroid treatment for BP in children is still inconclusive. Further studies are required.
Pediatric Otolaryngology Surgery for Pediatric Invasive Fungal Sinonasal Disease
Farhad Ardeshirpour, MD (presenter); Kiran Belani; Susan Sencer; James D. Sidman, MD; Timothy Lander, MD Objective: 1) Evaluate the management and outcomes of immunocompromised children with invasive fungal sinonasal disease who were treated with radical surgery. 2) Compare outcomes of radical surgery with less aggressive surgical debridements described in the literature.
Method:
From 1994 to 2007, eleven pediatric patients with invasive fungal sinonasal disease, who were treated by the same pediatric otolaryngologist, were retrospectively evaluated. Demographics, oncologic diagnoses, absolute neutrophil counts, symptoms, CT scan findings, biopsy and culture results, surgical procedures, anti-fungal therapies, outcomes, and survival were among the data collected.
Results: There were 4 males and 7 females with an average age of 10 years (range, 2-14 years). Ten of the patients had relapsed leukemias. Six patients had acute lymphoblastic leukemia, 5 had acute myeloid leukemia. The average number of severely neutropenic days prior to diagnosis of invasive fungal infection was 18 days (range, 8-41 days). Seven patients had alternaria, 4 had aspergillus. Nine patients underwent an external medial maxillectomy, 5 of which were bilateral, and six underwent septectomy. All eleven patients (100%) were cured of their invasive fungal sinonasal disease and did not relapse. Three patients eventually died from other causes.
Conclusion: Invasive fungal sinonasal disease is a life-threatening problem in immunocompromised children, especially with relapsed leukemia. Successful treatment depends on timely and aggressive surgical, anti-fungal, and supportive therapies. This is the largest series of pediatric patients with invasive fungal sinonasal disease who underwent aggressive surgery with the best outcomes to date.
